| Advanced age increases immunosuppression in the brain and decreases immunotherapeutic efficacy in subjects with glioblastoma E Ladomersky, L Zhai, KL Lauing, A Bell, J Xu, M Kocherginsky, B Zhang, ... Clinical Cancer Research 26 (19), 5232-5245, 2020 | 69 | 2020 |
| The impact of socioeconomic status (SES) on cognitive outcomes following radiotherapy for pediatric brain tumors: a prospective, longitudinal trial VA Torres, JM Ashford, E Wright, J Xu, H Zhang, TE Merchant, ... Neuro-oncology 23 (7), 1173-1182, 2021 | 45 | 2021 |
| Repeated rectal application of a hyperosmolar lubricant is associated with microbiota shifts but does not affect PrEP drug concentrations: results from a randomized trial in … RE Haaland, J Fountain, Y Hu, A Holder, C Dinh, LS Hall, NA Pescatore, ... African Journal of Reproduction and Gynaecological Endoscopy 21 (10), 2018 | 21 | 2018 |
| Montreal Cognitive Assessment (MoCA) performance and domain-specific index scores in amnestic versus aphasic dementia JL Wood, S Weintraub, C Coventry, J Xu, H Zhang, E Rogalski, ... Journal of the International Neuropsychological Society 26 (9), 927-931, 2020 | 20 | 2020 |
| Mucosal barrier injury–associated bloodstream infections in pediatric oncology patients H Hakim, AL Billett, J Xu, L Tang, T Richardson, C Winkle, EJ Werner, ... Pediatric Blood & Cancer 67 (8), e28234, 2020 | 17 | 2020 |
| Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: a multicenter, open-label, single-arm phase II study L Mao, M Fang, Y Chen, X Wei, J Cao, J Lin, P Zhang, L Chen, X Cao, ... Clinical Cancer Research 28 (21), 4642-4648, 2022 | 14 | 2022 |
| Clinical importance of free thyroxine concentration decline after radiotherapy for pediatric and adolescent brain tumors L Van Iersel, J Xu, BS Potter, HM Conklin, H Zhang, W Chemaitilly, ... The Journal of Clinical Endocrinology & Metabolism 104 (11), 4998-5007, 2019 | 10 | 2019 |
| A Big Ten Cancer Research Consortium phase II trial of pembrolizumab with carboplatin and paclitaxel for advanced or recurrent endometrial cancer. MJ Pineda, J Schilder, EK Hill, DGK Teoh, EL Barber, SE Robertson, ... Journal of clinical oncology 38 (15_suppl), 6022-6022, 2020 | 8 | 2020 |
| Effect of a shielded continuous ultraviolet-C air disinfection device on reduction of air and surface microbial contamination in a pediatric oncology outpatient care unit H Hakim, C Gilliam, L Tang, J Xu, LD Lee American journal of infection control 47 (10), 1248-1254, 2019 | 7 | 2019 |
| Phase II trial of guadecitabine priming and pembrolizumab in platinum resistant recurrent ovarian cancer. D Matei, A Pant, JW Moroney, GF Fleming, E Tanner, WM Swetzig, J Xu, ... Journal of Clinical Oncology 38 (15_suppl), 6025-6025, 2020 | 6 | 2020 |
| Tri-ethylene glycol modified class B and class C CpG conjugated gold nanoparticles for the treatment of lymphoma AY Lin, JS Rink, R Karmali, J Xu, M Kocherginsky, CS Thaxton, LI Gordon Nanomedicine: Nanotechnology, Biology and Medicine 30, 102290, 2020 | 5 | 2020 |
| The effects of temperature on dynamics of psychiatric outpatients Y Shao, J Xu, Y Qiao, Y Shao, JM Fei Frontiers in psychiatry 11, 523059, 2020 | 4 | 2020 |
| Treatment with pembrolizumab in combination with the oncolytic virus pelareorep promotes anti-tumor immunity in patients with advanced pancreatic adenocarcinoma. D Mahalingam, S Chen, P Xie, A Kalyan, SM Kircher, M Kocherginsky, ... Journal of Clinical Oncology 39 (15_suppl), 4144-4144, 2021 | 3 | 2021 |
| Safety and efficacy of atezolizumab in Chinese patients with previously treated locally advanced or metastatic non-small cell lung cancer: An open-label, single-arm … Y Xu, Z Huang, J Chang, Y Yu, C Liu, J Li, J Zhao, D Lv, S Sun, Q Zhang, ... Lung Cancer 183, 107288, 2023 | 2 | 2023 |
| Pembrolizumab in combination with the oncolytic virus pelareorep in patients progressing on systemic chemotherapy for advanced pancreatic adenocarcinoma: A phase II study. D Mahalingam, A Kalyan, SM Kircher, V Maurer, M Kocherginsky, J Xu, ... Journal of Clinical Oncology 38 (15_suppl), e16789-e16789, 2020 | 1 | 2020 |
| Atezolizumab and trastuzumab plus chemotherapy in patients with HER2+ locally advanced resectable gastric cancer or adenocarcinoma of the gastroesophageal junction: A … Z Peng, X Zhang, H Liang, Z Zheng, Z Wang, H Liu, J Hu, Y Sun, Y Zhang, ... Journal of Clinical Oncology 42 (3_suppl), 312-312, 2024 | | 2024 |
| EP12. 02-12 Matching-Adjusted Indirect Comparison (MAIC): Entrectinib versus Crizotinib in Asian Patients with ROS1+ NSCLC S Lu, Y Fan, Y Yu, X Dong, J Li, J Zhao, S Tao, M Chen, Y Chen, Y Liu, ... Journal of Thoracic Oncology 18 (11), S679, 2023 | | 2023 |
| Treatment decision making in metastatic prostate cancer (mPC). F Schumacher, J Xu, L Oswald, B Lee, B Gonzalez, H Zhang, AK Morgans Journal of Clinical Oncology 38 (15_suppl), e17552-e17552, 2020 | | 2020 |
| Language Development in Children Treated for Brain Tumors During Infancy: Outcomes from a Prospective, Longitudinal Trial JS Ali, J Ashford, M Swain, L Harder, Carlson-Green, JM Miller, J Wallace, ... CLINICAL NEUROPSYCHOLOGIST 33 (4), 663-664, 2019 | | 2019 |
| Characterizing Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections in Pediatric Hematology-Oncology Patients H Hakim, AL Billett, J Xu, L Tang, T Richardson, EJ Werner, AH Gaur SHEA Spring 2018, 2018 | | 2018 |
